Clinical trial · Observational
Study on Gynecological Rare Cancers
Prospective, Multicenter, Observational Study on Rare Gynecological Cancers
NCT05733806CI-TRIAL-00064196MITO9BrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a prospective, observational, multicenter study on gynecological rare tumors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gynecologic Cancer | Malignant Female Reproductive System Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| chemotherapy, surgery | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Gynecologic rare tumors
- description
- The study will include patients with rare gynecologic malignancies
- interventionNames
- Other: chemotherapy, surgery
Primary outcomes (1)
- measure
- Prevalence of gynecologic rare malignancies
- timeFrame
- 5 years
- description
- To describe the prevalence of gynecologic rare tumors
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: * rare gynecological malignancies * written informed consent * patient fit for follow-up Exclusion criteria -written informed consent not provided
References
Publications (0)
Data not yet available
No reference posted for this study.